Merck & Co, the original manufacturer of ivermectin, said there is not enough data available to support the use of the medication for Covid-19 patients, reported News24 (6 Feb 2021).

In terms of the Medicines and Related Substances Control Act, a Section 21 application is the process used to apply for the prescription of medicine not registered for human use in SA. An interim settlement was reached in the Gauteng High Court between SAHPRS, AfriForum and others to allow doctors, in cases deemed urgent, to start ivermectin treatment as soon as a Section 21 application has been submitted.

Other news